Details of the Drug | DrugMAP

General Information of Drug (ID: DM94IQ3)

Drug Name

Telcyta canfosfamide

Indication

Disease Entry	ICD 11	Status	REF
Diffuse large B-cell lymphoma	2A81	Phase 3	[1]
Mantle cell lymphoma	2A85.5	Phase 3	[1]
Non-hodgkin lymphoma	2B33.5	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D06BGO

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer.Eur J Cancer. 2009 Sep;45(13):2324-32.